Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 USD | +2.02% |
|
+8.92% | -15.91% |
24/06 | CureVac N.V. Approves the Appointment of Birgit Hofmann as a Member of the Supervisory Board | CI |
28/05 | CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.91% | 794M | |
+38.36% | 52.73B | |
+37.21% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- Transcript : CureVac N.V. Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 03